iSGTW is now Science Node Learn more about our evolution

  • Subscribe

AI points to better decision-making despite poker match loss

We often approach life as if it were a chess match, assuming every piece is visible. But that's seldom true. As Tuomas Sandholm of Carnegie Mellon University's School of Computer Science sees it, life is more like a hand of poker. Other players have cards we can't see, and they often try to trick us. Could our decisions be better if we leveraged artificial intelligence (AI)?

That's the question Sandholm and graduate students Noam Brown and Sam Ganzfried set out to answer. Using the Blacklight system at the Pittsburgh Supercomputing Center (PSC), they built Claudico, an AI poker player.

"We really didn't write a program called 'Claudico,'" Sandholm is quick to point out. "Claudico emerged from general-purpose algorithms we developed for solving incomplete information games."

Tuomas Sandholm talks with graduate students Noam Brown and Sam Ganzfried. Courtesy Ken Chiacchia.

The algorithms approximate game-theory-optimal play, subject to computational limitations. Heads-up, no-limit Texas Hold'em poker contains 10161 situations that a player might face. That outnumbers the atoms in the universe, and transcends any foreseeable computing capability.

"The first step is creating an abstraction," Sandholm explains. "The algorithm takes the rules of the game and outputs a smaller game that's strategically similar."

The algorithm abstracts by conflating similar hands - for example, possibly equating two Jacks with two Queens. But as the game progresses, this 'rounding off' error amplifies. To avoid this pitfall, CMU researchers used an allocation on Blacklight, a supercomputer in theUS National Science Foundation's XSEDE network. Blacklight's large cache-coherent memory allowed a much finer-grained abstraction than otherwise possible - in computing the strategy for Claudico, the researchers used an enormous 8 Terabytes of RAM.

Claudico outstrips the team's earlier AI, Tartanian7, which dominated the 2014 Annual Computer Poker Competition. But could Claudico surpass humanity's best, like when Deep Blue bested Kasparov in 1996 or Watson dominated Jeopardy! in 2011?

Playing a Martian

Claudico took on four of the world's 10 best poker players at the Rivers Casino in Pittsburgh, Pennsylvania, US from April 24 through May 8, 2015. Statistically, the contest was a tie, but in the end Claudico lost to human opponents. Wagers totaled $170 million virtual dollars, and Claudico wound up $732,713 behind.

"Claudico was a very strong opponent," said Doug Polk, the number one ranked poker player in the world. "It's extremely aggressive."

Doug Polk, the world's #1 ranked poker player. Courtesy Ken Chiacchia.

Polk noted that Claudico would risk tens of thousands of dollars to win hundreds. Human players often hesitate to take such risks, and pros succeed by being willing to lose in the short term for a strategy that will pay off in the long run. "Claudico just takes that to the next level," he says.

"Playing Claudico is like playing a Martian," Sandholm says. In particular, it likes to 'pass' on the first move - meeting the other player's bid without raising it or folding. Pros denigrate that as a rookie move, calling it 'limping.' But Claudico (from the Latin for 'I limp.') owns that strategy.

More than just a poker player

Despite losing against top human poker players, Claudico holds tremendous promise for enhancing our knowledge in other incomplete information domains.

For instance, in the uncertain world of threat assessment, deciding how to allocate physical and cyber security resources might be done more efficiently if AI could weigh the odds of a threat at a given place and time.

The medical field offers perhaps the most exciting possibilities. "Most medical treatment today is myopic," Sandholm explains. "We throw one treatment at a problem at a time. AI might help doctors design multi-step treatment plans with better outcomes."

A series of pharmaceutical 'nudges' might steer treatment of an HIV infection in which mutant viruses within a patient have different virulence and vulnerability. Similarly, therapies could steer cancer-cells toward less malignancy, or colonies of bacteria away from antibiotic resistance.

"That's a big vision and I'm very excited about it," Sandholm says.

--Ken Chiacchia, senior science writer at the Pittsburgh Supercomputing Center

Join the conversation

Do you have story ideas or something to contribute?
Let us know!

Copyright © 2015 Science Node ™  |  Privacy Notice  |  Sitemap

Disclaimer: While Science Node ™ does its best to provide complete and up-to-date information, it does not warrant that the information is error-free and disclaims all liability with respect to results from the use of the information.


We encourage you to republish this article online and in print, it’s free under our creative commons attribution license, but please follow some simple guidelines:
  1. You have to credit our authors.
  2. You have to credit — where possible include our logo with a link back to the original article.
  3. You can simply run the first few lines of the article and then add: “Read the full article on” containing a link back to the original article.
  4. The easiest way to get the article on your site is to embed the code below.